DPW
NVO

DiNuzzo Private Wealth’s Novo Nordisk NVO Stock Holding History

DiNuzzo Private Wealth’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.88K Hold
60
– – ﹤0.01% 553
2026
Q1 		$2.21K Hold
60
– – ﹤0.01% 608
2025
Q4 		$3.05K Hold
60
– – ﹤0.01% 503
2025
Q3 		$3.39K Hold
60
– – ﹤0.01% 468
2025
Q2 		$4.14K Hold
60
– – ﹤0.01% 413
2025
Q1 		$4.17K Hold
60
– – ﹤0.01% 395
2024
Q4 		$5.16K Hold
60
– – ﹤0.01% 348
2024
Q3 		$7.14K Buy
+60
New +$8K ﹤0.01% 299

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

DiNuzzo Private Wealth's NVO Position: Q2 2026 in Review

DiNuzzo Private Wealth held its Novo Nordisk (NVO) position steady in Q2 2026 at 60 shares worth $2.88K. The position accounts for ﹤0.01% of the portfolio, ranked #553.

DiNuzzo Private Wealth first reported a position in NVO in Q3 2024 and has held it in 8 quarters since. The position peaked at $7.14K in Q3 2024. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • DiNuzzo Private Wealth held 60 shares of Novo Nordisk worth $2.88K as of Q2 2026.
  • DiNuzzo Private Wealth left its Novo Nordisk share count unchanged in Q2 2026.
  • Novo Nordisk made up ﹤0.01% of DiNuzzo Private Wealth's portfolio in Q2 2026, its #553 holding.
  • DiNuzzo Private Wealth first reported a position in Novo Nordisk in Q3 2024 and has held it in 8 quarters since.
  • DiNuzzo Private Wealth's Novo Nordisk position peaked at $7.14K in Q3 2024.
  • 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on DiNuzzo Private Wealth's 13F filing for Q2 2026, filed 10 Jul 2026.